Skip to content
★ Sign in to follow
Total declarations
9
Company
1
▲ Purchases (5 ops.)
€107k
▼ Sales (0 ops.)
—

Latest filing published 06 Jun 2018 for Tonix Pharmaceuticals Holding Corp., €21k.

Filing timeline

BuySale
John B. Rhodes

Insider track record

Disclosed buys
5
Disclosed sells
0
Signal history

Closed purchases

Market purchases
5
Positive at T+90
0%
Median T+90
-70.5%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

John B. Rhodes: trading record in brief

John B. Rhodes is a declared insider of Tonix Pharmaceuticals Holding Corp., with filings sourced from SEC (Form 4). We count 9 filings; the first trade dates from 26 April 2013 and the latest from 1 June 2018.

No open-market sale appears; the market trades are 5 purchases worth €107k. No amount is published for 2 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 3 option exercises. Since January 2018: 1 purchase and no sales on the market.

Half of the purchases are above €41k and half below.

On 6 June 2018 came the latest disclosure, an open-market purchase for €21k in Tonix Pharmaceuticals Holding Corp. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to John B. Rhodes

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations7 total

7 of 7 declarations